Skip to main content

Advertisement

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

Article metrics

The original article was published in BMC Medicine 2019 17:18

Correction to: BMC Med

https://doi.org/10.1186/s12916-019-1257-1

The original article [1] contained two minor errors:

  1. 1)

    Author, Chee H. Ng’s middle initial was omitted;

  2. 2)

    The Competing Interests declaration omitted some information regarding author, Chee H. Ng.

These two errors have since been corrected.

Reference

  1. 1.

    Berk M, et al. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med. 2019;17:18 https://doi.org/10.1186/s12916-019-1257-1.

Download references

Author information

Correspondence to Michael Berk.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Berk, M., Turner, A., Malhi, G.S. et al. Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med 17, 35 (2019) doi:10.1186/s12916-019-1280-2

Download citation